These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia. Ingannato A; Bagnoli S; Mazzeo S; Giacomucci G; Bessi V; Ferrari C; Sorbi S; Nacmias B Front Endocrinol (Lausanne); 2024; 15():1375302. PubMed ID: 38654932 [TBL] [Abstract][Full Text] [Related]
7. Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression. Rabl M; Zullo L; Lewczuk P; Kornhuber J; Karikari TK; Blennow K; Zetterberg H; Bavato F; Quednow BB; Seifritz E; von Gunten A; Clark C; Popp J Res Sq; 2024 Mar; ():. PubMed ID: 38562890 [TBL] [Abstract][Full Text] [Related]
8. Combination of plasma amyloid beta Verberk IMW; Thijssen E; Koelewijn J; Mauroo K; Vanbrabant J; de Wilde A; Zwan MD; Verfaillie SCJ; Ossenkoppele R; Barkhof F; van Berckel BNM; Scheltens P; van der Flier WM; Stoops E; Vanderstichele HM; Teunissen CE Alzheimers Res Ther; 2020 Sep; 12(1):118. PubMed ID: 32988409 [TBL] [Abstract][Full Text] [Related]
9. The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment. Mazzeo S; Ingannato A; Giacomucci G; Bagnoli S; Cavaliere A; Moschini V; Balestrini J; Morinelli C; Galdo G; Emiliani F; Piazzesi D; Crucitti C; Frigerio D; Polito C; Berti V; Padiglioni S; Sorbi S; Nacmias B; Bessi V Neurol Sci; 2024 Mar; 45(3):1031-1039. PubMed ID: 37723371 [TBL] [Abstract][Full Text] [Related]
10. Clinical and biological relevance of glial fibrillary acidic protein in Alzheimer's disease. Yang Z; Sreenivasan K; Toledano Strom EN; Osse AML; Pasia LG; Cosme CG; Mugosa MRN; Chevalier EL; Ritter A; Miller JB; Cordes D; Cummings JL; Kinney JW Alzheimers Res Ther; 2023 Nov; 15(1):190. PubMed ID: 37924152 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer's disease-associated biomarkers alterations among de novo Parkinson's disease patients: a prospective cohort study. Liu T; Zuo H; Ma D; Song D; Zhao Y; Cheng O J Neuroinflammation; 2023 Jul; 20(1):167. PubMed ID: 37475029 [TBL] [Abstract][Full Text] [Related]
12. Plasma p-tau Frank B; Ally M; Brekke B; Zetterberg H; Blennow K; Sugarman MA; Ashton NJ; Karikari TK; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Simkina I; Turk KW; Budson AE; O'Connor MK; Au R; Goldstein LE; Jun GR; Kowall NW; Stein TD; McKee AC; Killiany R; Qiu WQ; Stern RA; Mez J; Alosco ML Alzheimers Dement; 2022 Aug; 18(8):1523-1536. PubMed ID: 34854549 [TBL] [Abstract][Full Text] [Related]
13. Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer's disease. Parvizi T; König T; Wurm R; Silvaieh S; Altmann P; Klotz S; Rommer PS; Furtner J; Regelsberger G; Lehrner J; Traub-Weidinger T; Gelpi E; Stögmann E Front Aging Neurosci; 2022; 14():887498. PubMed ID: 36072480 [No Abstract] [Full Text] [Related]
14. Relationship between topological efficiency of white matter structural connectome and plasma biomarkers across the Alzheimer's disease continuum. Zhang M; Chen H; Huang W; Guo T; Ma G; Han Y; Shu N Hum Brain Mapp; 2024 Jan; 45(1):e26566. PubMed ID: 38224535 [TBL] [Abstract][Full Text] [Related]
15. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy. Chouliaras L; Thomas A; Malpetti M; Donaghy P; Kane J; Mak E; Savulich G; Prats-Sedano MA; Heslegrave AJ; Zetterberg H; Su L; Rowe JB; O'Brien JT J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):651-658. PubMed ID: 35078917 [TBL] [Abstract][Full Text] [Related]